---
title: "The biopharmaceutical sector experiences a volatile rebound, with Konruns hitting the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249492021.md"
description: "The biopharmaceutical sector experienced a volatile rebound, with Konruns hitting the limit up, followed by gains in Baiao Tai, Saiseng Pharmaceutical, Hite Bio, Eddie Pharmaceutical, Saifen Technology, Junshi Biosciences, and others"
datetime: "2025-07-22T01:52:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249492021.md)
  - [en](https://longbridge.com/en/news/249492021.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249492021.md)
generator: "portal-rs"
---

# The biopharmaceutical sector experiences a volatile rebound, with Konruns hitting the daily limit

The biopharmaceutical sector experienced a volatile rebound, with Konruns hitting the limit up, followed by gains in Baiao Tai, Saiseng Pharmaceutical, Hite Bio, Eddie Pharmaceuticals, Saifen Technology, Junshi Biosciences, and others

### Related Stocks

- [603590.CN](https://longbridge.com/en/quote/603590.CN.md)

## Related News & Research

- [Think Medicare Advantage provides better care for chronic conditions? A new study suggests otherwise.](https://longbridge.com/en/news/296807815.md)
- [15:53 ETFoundations to Freedom Named Primary Partner of Carson Ware for the Winn-Dixie 250 at Daytona International Speedway](https://longbridge.com/en/news/296823183.md)
- [Subscribe for Symbiotec Pharmalab Ltd IPO; Ajcon Global](https://longbridge.com/en/news/296742246.md)
- [18:00 ETMiles for Mercy raises more than $4,000 before riders hit the road](https://longbridge.com/en/news/296958797.md)
- [Qlife enters fully funded feasibility deal with global pharma company for Egoo Health biomarker application](https://longbridge.com/en/news/296995766.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**